CYTOSORBENTS CORPORATION (CTSO) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -18.21M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-18.21M | (m) |
| 2026-03-31 | (m) | $-11.85M | (m) |
| 2025-12-31 | (m) | $-8.20M | (m) |
| 2025-09-30 | (m) | $-10.27M | (m) |
| 2025-06-30 | (m) | $-9.87M | (m) |
| 2025-03-31 | (m) | $-16.11M | (m) |
| 2024-12-31 | (m) | $-20.72M | (m) |
| 2024-09-30 | (m) | $-18.67M | (m) |
| 2024-06-30 | (m) | $-25.53M | (m) |
| 2024-03-31 | (m) | $-27.54M | (m) |
| 2023-12-31 | (m) | $-28.51M | (m) |
| 2023-09-30 | (m) | $-23.44M | (m) |
| 2023-06-30 | (m) | $-26.45M | (m) |
| 2023-03-31 | (m) | $-31.17M | (m) |
| 2022-12-31 | (m) | $-32.81M | (m) |
| 2022-09-30 | (m) | $-41.35M | (m) |
| 2022-06-30 | (m) | $-35.56M | (m) |
| 2022-03-31 | (m) | $-29.36M | (m) |
| 2021-12-31 | (m) | $-24.56M | (m) |
| 2021-09-30 | (m) | $-15.93M | (m) |
| 2021-06-30 | (m) | $-10.36M | (m) |
| 2021-03-31 | (m) | $-8.55M | (m) |
| 2020-12-31 | (m) | $-7.84M | (m) |
| 2020-09-30 | (m) | $-11.11M | (m) |
| 2020-06-30 | (m) | $-17.15M | (m) |
| 2020-03-31 | (m) | $-17.83M | (m) |
| 2019-12-31 | (m) | $-19.27M | (m) |
| 2019-09-30 | (m) | $-20.72M | (m) |
| 2019-06-30 | (m) | $-16.84M | (m) |
| 2019-03-31 | (m) | $-19.11M | (m) |
| 2018-12-31 | (m) | $-17.21M | (m) |
| 2018-09-30 | (m) | $-14.96M | (m) |
| 2018-06-30 | (m) | $-14.00M | (m) |
| 2018-03-31 | (m) | $-9.92M | (m) |
| 2017-12-31 | (m) | $-8.46M | (m) |
| 2017-09-30 | (m) | $-10.40M | (m) |
| 2017-06-30 | (m) | $-9.59M | (m) |
| 2017-03-31 | (m) | $-11.48M | (m) |
| 2016-12-31 | (m) | $-11.94M | (m) |
| 2016-09-30 | (m) | $-9.53M | (m) |
| 2016-06-30 | (m) | $-9.69M | (m) |
| 2016-03-31 | (m) | $-5.25M | (m) |
| 2015-12-31 | (m) | $-8.13M | (m) |
| 2015-09-30 | (m) | $-11.12M | (m) |
| 2015-06-30 | (m) | $-9.78M | (m) |
| 2015-03-31 | (m) | $-13.06M | (m) |
| 2014-12-31 | (m) | $-9.32M | (m) |
| 2014-09-30 | (m) | $-5.00M | (m) |
| 2014-06-30 | (m) | $-4.46M | (m) |
| 2014-03-31 | (m) | $-4.02M | (m) |
| 2013-12-31 | (m) | $-4.68M | (m) |
| 2013-09-30 | (m) | $-4.55M | (m) |
| 2013-06-30 | (m) | $-4.23M | (m) |
| 2013-03-31 | (m) | $-3.87M | (m) |
| 2012-12-31 | (m) | $-3.66M | (m) |
| 2012-09-30 | (m) | $-4.32M | (m) |
| 2012-06-30 | (m) | $-5.40M | (m) |
| 2012-03-31 | (m) | $-5.69M | (m) |
| 2011-12-31 | (m) | $-5.48M | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $-2.91M | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2009-12-31 | (m) | $-2.74M | (m) |
| 2008-12-31 | (m) | $-3.02M | (m) |
| 2007-12-31 | (m) | $-3.35M | (m) |
| 2006-12-31 | (m) | $-7.67M | (m) |
| 2005-12-31 | (m) | $-3.67M | (m) |
| 2004-12-31 | (m) | $-1.10M | (m) |
| 2003-12-31 | (m) | $-6.01M | (m) |
| 2002-12-31 | (m) | $-11.87M | (m) |
| 2001-12-31 | (m) | $-15.39M | (m) |
| 2000-12-31 | (m) | $-10.75M | (m) |
| 1999-12-31 | (m) | $-3.07M | (m) |
| 1998-12-31 | (m) | $-1.87M | (m) |
| 1997-12-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |